StonvexLoading…
StonvexStonvexStonvexCore line items from SLSN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $62.06M | $52.35M | $37.30M | $37.32M |
Operating Income | $1.57M | $5.13M | $-3.55M | $-2.26M |
Net Income | $1.79M | $4.24M | $-4.39M | $-2.62M |
EPS (Diluted) | $0.02 | $0.07 | $-0.09 | $-0.05 |
Total Assets | $50.05M | $50.00M | $32.88M | $33.56M |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $1.29M | $1.41M | $1.72M | $2.19M |
Free Cash Flow OCF − CapEx | Not available | $-2.59M | $-3.06M | $-4.47M |
Shares Outstanding | 70.61M | 70.10M | 49.63M | 49.32M |